E. Davasaz Tabrizi Et Al. , "Chronic Prostatitis Disease,Pharmaceutical Therapy And Urinary Microbiome," JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS , vol.13, no.10, pp.6642-6649, 2023
Davasaz Tabrizi, E. Et Al. 2023. Chronic Prostatitis Disease,Pharmaceutical Therapy And Urinary Microbiome. JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS , vol.13, no.10 , 6642-6649.
Davasaz Tabrizi, E., Mushteba, S., & Arıcan, E., (2023). Chronic Prostatitis Disease,Pharmaceutical Therapy And Urinary Microbiome. JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS , vol.13, no.10, 6642-6649.
Davasaz Tabrizi, Elmira, Sevil Mushteba, And Ercan ARICAN. "Chronic Prostatitis Disease,Pharmaceutical Therapy And Urinary Microbiome," JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS , vol.13, no.10, 6642-6649, 2023
Davasaz Tabrizi, Elmira D. Et Al. "Chronic Prostatitis Disease,Pharmaceutical Therapy And Urinary Microbiome." JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS , vol.13, no.10, pp.6642-6649, 2023
Davasaz Tabrizi, E. Mushteba, S. And Arıcan, E. (2023) . "Chronic Prostatitis Disease,Pharmaceutical Therapy And Urinary Microbiome." JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS , vol.13, no.10, pp.6642-6649.
@article{article, author={Elmira Davasaz Tabrizi Et Al. }, title={Chronic Prostatitis Disease,Pharmaceutical Therapy And Urinary Microbiome}, journal={JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS}, year=2023, pages={6642-6649} }